 Connection
Bradley Martin to Medicaid
This is a "connection" page, showing publications Bradley Martin has written about Medicaid.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.925 |
|
|
|
-
Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011 Dec; 26(12):1450-7.
Score: 0.323
-
Sullivan MD, Edlund MJ, Fan MY, DeVries A, Braden JB, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008 Aug 31; 138(2):440-449.
Score: 0.261
-
Chen H, Kennedy WK, Dorfman JH, Fincham JE, Reeves J, Martin BC. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Curr Med Res Opin. 2007 Jun; 23(6):1351-65.
Score: 0.242
-
Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. J Clin Psychiatry. 2006 Jun; 67(6):972-82.
Score: 0.227
-
Chen H, Deshpande AD, Jiang R, Martin BC. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiol Drug Saf. 2005 Sep; 14(9):629-38.
Score: 0.215
-
Sapra S, Nielsen K, Martin BC. The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs. J Asthma. 2005 Jul-Aug; 42(6):469-77.
Score: 0.213
-
Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry. 2004 Oct; 65(10):1377-88.
Score: 0.202
-
Martin BC, Ganguly R, Pannicker S, Frech F, Barghout V. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome. Curr Med Res Opin. 2003; 19(8):771-80.
Score: 0.179
-
Chopra D, Li C, Painter JT, Bona JP, Nookaew I, Martin BC. Characteristics and Network Influence of Providers Involved in the Treatment of Patients With Chronic Back, Neck or Joint Pain in Arkansas. J Pain. 2021 12; 22(12):1681-1695.
Score: 0.161
-
Goudie A, Martin B, Li C, Lewis K, Han X, Kathe N, Wilson JC, Thompson J. Higher Rates of Preventive Health Care With Commercial Insurance Compared With Medicaid: Findings From the Arkansas Health Care Independence "Private Option" Program. Med Care. 2020 02; 58(2):120-127.
Score: 0.146
-
Richardson LP, Fan MY, McCarty CA, Katon W, Edlund M, DeVries A, Martin BC, Sullivan M. Trends in the prescription of opioids for adolescents with non-cancer pain. Gen Hosp Psychiatry. 2011 Sep-Oct; 33(5):423-8.
Score: 0.080
-
Domino ME, Martin BC, Wiley-Exley E, Richards S, Henson A, Carey TS, Sleath B. Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment. Health Serv Res. 2011 Jun; 46(3):900-19.
Score: 0.078
-
Sullivan MD, Edlund MJ, Fan MY, DeVries A, Braden JB, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain. 2010 Aug; 150(2):332-339.
Score: 0.075
-
Pathak P, West D, Martin BC, Helm ME, Henderson C. Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. Psychiatr Serv. 2010 Feb; 61(2):123-9.
Score: 0.073
-
Thielke SM, Simoni-Wastila L, Edlund MJ, DeVries A, Martin BC, Braden JB, Fan MY, Sullivan MD. Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med. 2010 Feb; 11(2):248-56.
Score: 0.072
-
Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009 Sep; 25(9):2303-10.
Score: 0.071
-
Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health. 2009 Sep; 12(6):989-95.
Score: 0.069
-
Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009 Jan; 43(1):36-44.
Score: 0.068
-
Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008 Nov; 46(11):1125-33.
Score: 0.067
-
Miller LS, Martin BC. Current and future forecasts of service use and expenditures of Medicaid-eligible schizophrenia patients in the state of Georgia. Schizophr Bull. 2004; 30(4):983-95.
Score: 0.048
-
Edlund MJ, Martin BC, Fan MY, Braden JB, Devries A, Sullivan MD. An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study. J Pain Symptom Manage. 2010 Aug; 40(2):279-89.
Score: 0.019
-
Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010 Jan; 26(1):1-8.
Score: 0.018
-
Sleath B, Domino ME, Wiley-Exley E, Martin B, Richards S, Carey T. Antidepressant and antipsychotic use and adherence among Medicaid youths: differences by race. Community Ment Health J. 2010 Jun; 46(3):265-72.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|